CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Malabre Richard C SVP, Chief Accounting Officer | Sale 10b5-1 | −36,142 | $1.39 | $50K | 312,772 |
| 2026-02-02 | Malabre Richard C SVP, Chief Accounting Officer | Sale 10b5-1 | −13,382 | $1.39 | $19K | 299,390 |
| 2026-02-02 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −34,951 | $1.39 | $49K | 672,635 |
| 2026-02-02 | Grund Nicholas Chief Commercial Officer | Sale 10b5-1 | −53,585 | $1.39 | $74K | 592,994 |
| 2026-02-02 | Grund Nicholas Chief Commercial Officer | Sale 10b5-1 | −31,244 | $1.39 | $43K | 561,750 |
| 2026-02-02 | Burke Steven Keith SVP, Chief Medical Officer | Sale 10b5-1 | −21,582 | $1.39 | $30K | 994,508 |
| 2026-02-02 | Burke Steven Keith SVP, Chief Medical Officer | Sale 10b5-1 | −25,375 | $1.39 | $35K | 969,133 |
| 2026-02-02 | Burke Steven Keith SVP, Chief Medical Officer | Sale 10b5-1 | −20,701 | $1.39 | $29K | 948,432 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −46,660 | $1.39 | $65K | 3,417,189 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −96,065 | $1.39 | $134K | 3,321,124 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −114,891 | $1.39 | $160K | 3,206,233 |
| 2026-02-02 | Butler John P. CEO and President | Grant or award 10b5-1 | +175,250 | $1.41 | $247K | 3,381,483 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −83,689 | $1.39 | $116K | 3,297,794 |
| 2026-01-30 | Rucci Carolyn M. SVP, Chief Legal Officer | Grant or award | +190,000 | 658,150 | ||
| 2026-01-30 | Rucci Carolyn M. SVP, Chief Legal Officer | Grant or award · Stock Option (Right to buy) | +270,000 | 270,000 | ||
| 2026-01-30 | Malabre Richard C SVP, Chief Accounting Officer | Grant or award | +79,000 | 348,914 | ||
| 2026-01-30 | Malabre Richard C SVP, Chief Accounting Officer | Grant or award · Stock Option (Right to buy) | +119,000 | 119,000 | ||
| 2026-01-30 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award | +204,000 | 707,586 | ||
| 2026-01-30 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award · Stock Option (Right to buy) | +320,000 | 320,000 | ||
| 2026-01-30 | Grund Nicholas Chief Commercial Officer | Grant or award | +204,000 | 646,579 |
Page 2 of 21 · 405 trades